TABLE 4.

SNOT-22 total score stratified mixed-effects models—difference in model estimates between fourth Q and first Q at 3-, 6-, and 12-month time periods^*

Patients’ strata	3 months	p	6 months	p	12 months	p
CRSwNP	−12.1 (−19.1 to −5.0)	0.001	−14.7 (−23.4 to −6.0)	0.001	−20.6 (−31.2 to −10.1)	<0.001
CRSsNP	−18.0 (−27.2 to −8.9)	<0.001	−15.0 (−25.1 to −4.9)	0.004	−8.0 (−20.5 to 4.4)	0.207
Primary	−12.7 (−20.7 to −4.8)	0.002	−12.7 (−21.9 to −3.5)	0.007	−12.3 (−23.2 to −1.3)	0.028
Revision	−17.7 (−23.2 to −12.2)	<0.001	−13.9 (−20.6 to −7.3)	<0.001	−14.4 (−22.1, −6.7)	<0.001

^*Refer to Table 1 for group sizes.

CRSwNP = chronic rhinosinusitis with nasal polyps; CRSsNP = chronic rhinosinusitis without nasal polyps; Primary = surgery performed during the study period was their first functional endoscopic sinus surgery; Revision = surgery performed during the study period was not their first functional endoscopic sinus surgery.